Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 May;82(6):633-656.
doi: 10.1002/pros.24311. Epub 2022 Feb 8.

A systematic review and meta-analysis of placebo effect in clinical trials on chronic prostatitis/chronic pelvic pain syndrome

Andrey Morozov  1 , Andrey Bazarkin  2 , Diana Babaevskaya  2 , Mark Taratkin  1 , Vasily Kozlov  3 , Aleksandr Suvorov  4 , Leonid Spivak  1 , Jonathan McFarland  5   6 , Giorgio I Russo  7 , Dmitry Enikeev  1 ; EAU-YAU Sexual and Reproductive Health Working Group
Affiliations
Meta-Analysis

A systematic review and meta-analysis of placebo effect in clinical trials on chronic prostatitis/chronic pelvic pain syndrome

Andrey Morozov et al. Prostate. 2022 May.

Abstract

Background: It is a common practice to control efficacy of pharmacological treatment with a placebo group. However, placebo itself may affect subjective and even objective results. The purpose of this study was to evaluate the placebo effect on symptoms of CP/CPPS to improve future clinical trials.

Methods: A search at three databases (Scopus, MEDLINE, and Web of Science) was conducted to identify double-blind placebo-controlled clinical trials on the treatment of CP/CPPS published until April 2021. The primary outcome - National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) score.

Secondary outcomes: Qmax, PVR, IPSS, and prostate volume.

Results: A total of 3502 studies were identified. Placebo arms of 42 articles (5512 patients, median 31 patients) were included in the systematic review. Systematic review identified positive changes in the primary endpoint, meta-analysis of 10 articles found that NIH-CPSI total score results were significantly influenced by placebo, mean difference -4.2 (95% confidence interval [CI]: -6.31, -2.09). Mean difference of NIH-CPSI pain domain was -2.31 (95% CI: -3.4, -1.21), urinary domain -1.12 (95% CI: -1.62, -0.62), quality of life domain -1.67 (95% CI: -2.38, -0.96); p < 0.001 for all. In case of the objective indicator - Qmax, there were three articles included in the meta-analysis. Qmax mean change from baseline was 0.68 (95% CI: -0.85, 2.22, p = 0.38). Systematic review showed no significant changes in pain, measured by VAS or other scores, IPSS and PVR.

Conclusions: Placebo significantly affected the subjective parameters (NIH-CPSI) and limitedly affected various other measurements of pain (visual analog scale, McGill pain questionnaire). There was no long-term effect on IPSS and objective measurements (Qmax, PVR). This study can be used in further clinical trials to develop general rules of CPPS treatment assessment.

Keywords: CP/CPPS; NIH-CPSI; chronic prostatitis; meta-analysis; placebo.

PubMed Disclaimer

References

REFERENCES

    1. Kwon JK, Chang IH. Pain, catastrophizing, and depression in chronic prostatitis/chronic pelvic pain syndrome. Int Neurourol J. 2013;17(2):48-58. doi:10.5213/INJ.2013.17.2.48
    1. Mändar R, Korrovits P, Rahu K, et al. Dramatically deteriorated quality of life in men with prostatitis-like symptoms. Andrology. 2020;8(1):101-109. doi:10.1111/andr.12647
    1. Habermacher GM, Chason JT, Schaeffer AJ. Prostatitis/chronic pelvic pain syndrome. Annu Rev Med. 2006;57:195-206. doi:10.1146/ANNUREV.MED.57.011205.135654
    1. Chen X, Zhou Z, Qiu X, Wang B, Dai J. The effect of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) on erectile function: a systematic review and meta-analysis. PLoS One. 2015;10(10):0141447. doi:10.1371/JOURNAL.PONE.0141447
    1. Hu Y, Niu X, Wang G, Huang J, Liu M, Peng B. Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model. Andrology. 2016;4(6):1209-1216. doi:10.1111/andr.12273

Publication types